Searchable abstracts of presentations at key conferences in endocrinology

ea0097006 | Section | BES2023

Effects of Long-term Testosterone Treatment in Transgender People without Gender-Affirming Surgery: the ELANTES study

Karen Decaestecker , Jeroen Vervalcke , Visschere Pieter De , Steven Weyers , Guy T'Sjoen

Background: Since pelvic gender-affirming surgery (GAS) is no longer required for legal gender change, we expect a growing number of transgender men and gender nonbinary people who refrain from pelvic surgery. Little is known about the effects of long-term testosterone use on the reproductive organs. Polycystic ovaries and endometrial changes have been described in previous histology-based studies. Furthermore, cervical cancer screening (CCS) is still recommen...

ea0099oc10.4 | Oral Communications 10: Calcium and Bone | Part II | ECE2024

Morning urinary Calcium/Creatinine Ratio as screening tool for hypercalciuria in patients with hypoparathyroidism

Berr Christina , Fuss Carmina Teresa , Gronemeyer Karen , Pfob Christian , Pusl Thomas , Hahner Stefanie

Background: Hypercalciuria is a relevant complication in patients with treated hypoparathyroidism. Hypercalciuria is usually estimated by 24 h urinary calcium excretion (24 hUCa). In contrast, in pediatric endocrinology the calcium-creatinine-ratio (CaCrR) is more often used due to feasibility. This study aims to compare these two approaches in adult patients with hypoparathyroidism.Methods: In 181 systematically evaluated patients with primary hypoparat...

ea0099p306 | Endocrine-Related Cancer | ECE2024

Long-acting starch (Glycosade(R)): An effective treatment for insulinoma-induced hypoglycemia – A case report

Arias Karen Andrea Castillo , Duminy Diego , Mora Mireia , Vinals Clara , Hanzu Felicia A , OROIS AIDA , Pane Adriana

Introduction: Insulinoma is a rare, generally benign neuroendocrine tumor, primarily manifesting as hypoglycemia in non-diabetic patients. Although surgery is the gold standard treatment for insulinoma, managing hypoglycemia becomes challenging in cases where surgery is not feasible. This challenge arises due to significant side effects that often limit the use of most drugs and therapeutic alternatives.Case report: A 90-year-old non-diabetic man was adm...

ea0099p588 | Late-Breaking | ECE2024

Psychiatric comorbidities in chronic hypoparathyroidism – a german single-center analysis in 133 patients

Teresa Fuss Carmina , Hermes Franca , Gronemeyer Karen , Koschker Ann-Cathrin , Unterecker Stefan , Deckert Jurgen , Hahner Stefanie

Introduction: Reduction of quality of life in patients with chronic hypoparathyroidism (HPT) has been reported by several studies. Additionally, self-report data point to a higher prevalence of anxiety disorders in HPT compared to patients after thyroidectomy.Objectives: To characterize psychiatric diseases in a systematically reviewed cohort of patients with chronic HPT.Methods: We systematically assessed psychiatric comorbidities...

ea0099ep396 | Reproductive and Developmental Endocrinology | ECE2024

Low dose estradiol gender-affirming hormone therapy (GAHT) generates rapid feminizing body changes in transgender women: a dual energy x-ray absorptiometry-based prospective study

Yaish Iris , Gindis Guy , Buch Asaf , Sofer Yael , Greenman Yona , Arbiv Mira , Moshe Yaffa , Tordjman Karen

Background and Aim: We previously demonstrated that low-dose estradiol (E2) administered sublingually alone for 6 months in treatment-naïve trans women (TW), suppressed testosterone to the same degree, but generated higher serum E2 levels as the same oral dose combined with cyproterone acetate. We now sought to assess the possible differential impact of these approaches on anthropometric and body composition measurements, sex-dependent indicators with proven metabolic pro...

ea0099ep592 | Reproductive and Developmental Endocrinology | ECE2024

Low dose sublingual estradiol decreases protein s, generating a potentially pro-thrombotic state: interim results of a controlled prospective pilot study of treatment-naïve trans women

Bar On Shelly , Yaish Iris , Barzilai Merav , Greenman Yona , Gindis Guy , Moshe Yaffa , Tordjman Karen

Background: Sublingual estradiol (E) for gender-affirming hormone therapy (GAHT) of transgender women (TW) might obviate the need for an anti-androgen, and mitigate pro-coagulant changes. We recently showed that 2 mg E, divided into 4 daily SL doses (SLE), offers no clinical advantage over the same dose given orally in combination with cyproterone acetate (CPA). Furthermore, we showed that after each sublingual administration, serum E2 (sE2) peaked to levels, the likes of whic...

ea0081p231 | Thyroid | ECE2022

Congestive heart failure as a first-time presentation of thyrotoxicosis in COVID-19 positive patient

McKay Ellen , Elhilo Mousa Kalthoom , Abrar Ul Haq Muhammad , Kelly Karen , Shafi Rummun Mohamad , Fleming Sean , Pyeh Kyithar Ma

Background: The clinical manifestations of thyrotoxicosis do not always correlate with the extent of thyroid biochemical abnormalities. Here, we report the case of a COVID-19 positive patient who presented with congestive heart failure as a first-time presentation of thyrotoxicosis. Case report: A 40-year-old female presented to Emergency Department with two days history of lower limb oedema and abdominal distension. She denied dyspnoea, chest pain, palp...

ea0090rc8.4 | Rapid Communications 8: Calcium and Bone | ECE2023

Encaleret (CLTX-305) normalized mineral homeostasis parameters in patients with autosomal dominant hypocalcemia type 1: Results over 12 months in a phase 2 study (NCT04581629)

Collins Michael , Hartley Iris , Roszko Kelly , Nemeth Edward , Pozo Karen , Boykin Winsome , Mathew Arun , Roberts Mary Scott , Adler Scott

Autosomal dominant hypocalcemia type 1 (ADH1), caused by gain-of-function calcium-sensing receptor gene (CASR) variants, is characterized by low parathyroid hormone (PTH) levels, hypocalcemia, hypercalciuria, hyperphosphatemia and hypomagnesemia. Conventional therapy (calcium and active vitamin D) worsens hypercalciuria, which may result in renal complications. Calcilytics, such as encaleret, are negative allosteric modulators of the calcium-sensing receptor (CaSR). T...

ea0090p182 | Reproductive and Developmental Endocrinology | ECE2023

Sublingual estradiol only, offers no apparent advantage over combined oral estradiol and cyproterone acetate, for Gender Affirming Hormone Therapy (GAHT) of treatment-naïve transwomen: Results of a prospective pilot study

Gindis Guy , Yaish Iris , Greenman Yona , Moshe Yaffa , Arbiv Mira , Buch Asaf , Sofer Yael , Shefer Gabi , Tordjman Karen

Background: The standard approach for Gender-Affirming Hormone Therapy (GAHT) of transgender women (TW) in Israel is oral estradiol (OE) combined with the potent anti-androgen cyproterone acetate (CA). Recently, many of our non-binary patients have requested sublingual estradiol (SLE) without CA, under the unproven belief it preserves erectile function, and does not induce depression. Preliminary data in a few subjects, who self-practiced this approach, suggested it also maint...

ea0090ep1070 | Thyroid | ECE2023

A Case of Myxoedema Coma Presenting as Suspected Angioedema with Confusion

Jatinder Hayre , Etbinah Lubna , Mohamed Ayan , Mahamud Bashir , Tam Karen , Mohammed Ahmed , Nikookam Khash , Mohammed Mohammed , Mlawa Gideon

Background: Myxoedema coma although uncommon can be life-threatening in patients who are poorly compliant with levothyroxine replacement. Some of the precipitating factors include intercurrent respiratory infection, use of sedatives, and electrolyte imbalance such as hyponatremia(Wiersinga 2018). A 73-year-old man presented to the Hospital with face and tongue swelling, shortness of breath, and type 2 respiratory failure. His past medical history includes hypothyroidism, Obstr...